Migration Stimulating Factor (MSF) is a 70 kDa truncated isoform of fibronectin (FN); its mRNA is generated from the FN gene by an unusual two-stage processing. Unlike full-length FN, MSF is not a matrix molecule but a soluble protein which displays cytokine-like activities not displayed by any other FN isoform due to steric hindrance. There are two isoforms of MSF; these are referred to as MSF+aa and MSF-aa, while the term MSF is used to include both.MSF was first identified as a motogen secreted by foetal and cancer-associated fibroblasts in tissue culture. It is also produced by sprouting (angiogenic) endothelial cells, tumour cells and activated macrophages. Keratinocytes and resting endothelial cells secrete inhibitors of MSF that have been identified as NGAL and IGFBP-7, respectively. MSF+aa and MSF-aa show distinct functionality in that only MSF+aa is inhibited by NGAL.MSF is present in 70-80% of all tumours examined, expressed by the tumour cells as well as by fibroblasts, endothelial cells and macrophages in the tumour microenvironment (TME). High MSF expression is associated with tumour progression and poor prognosis in all tumours examined, including breast carcinomas, non-small cell lung cancer (NSCLC), salivary gland tumours (SGT) and oral squamous cell carcinomas (OSCC). Epithelial and stromal MSF carry independent prognostic value. MSF is also expressed systemically in cancer patients, being detected in serum and produced by fibroblast from distal uninvolved skin. MSF-aa is the main isoform associated with cancer, whereas MSF+aa may be expressed by both normal and malignant tissues.The expression of MSF is not invariant; it may be switched on and off in a reversible manner, which requires precise interactions between soluble factors present in the TME and the extracellular matrix in contact with the cells. MSF expression in fibroblasts may be switched on by a transient exposure to several molecules, including TGFβ1 and MSF itself, indicating an auto-inductive capacity.Acting by both paracrine and autocrine mechanisms, MSF stimulates cell migration/invasion, induces angiogenesis and cell differentiation and alters the matrix and cellular composition of the TME. MSF is also a survival factor for sprouting endothelial cells. IGD tri- and tetra-peptides mimic the motogenic and angiogenic activities of MSF, with both molecules inhibiting AKT activity and requiring αvβ3 functionality. MSF is active at unprecedently low concentrations in a manner which is target cell specific. Thus, different bioactive motifs and extracellular matrix requirements apply to fibroblasts, endothelial cells and tumour cells. Unlike other motogenic and angiogenic factors, MSF does not affect cell proliferation but it stimulates tumour growth through its angiogenic effect and downstream mechanisms.The epithelial-stromal pattern of expression and range of bioactivities displayed puts MSF in the unique position of potentially promoting tumour progression from both the "seed" and the "soil" perspectives.

Department of Oral and Maxillofacial Surgery Yamaguchi University Graduate School of Medicine Yamaguchi Japan

Department of Pathophysiology Faculty of Medicine Masaryk University Brno Czech Republic

School of Dentistry University of Dundee Dundee UK

School of Science and Engineering University of Dundee Dundee UK

Zobrazit více v PubMed

Aljorani LE, Bankfalvi A, Carey FA, Harada K, Ohe G, Jones SJ, Ellis IR, Schor SL, Schor AM (2011) Migration-stimulating factor as a novel biomarker in salivary gland tumours. J Oral Pathol Med 40:747–754. https://doi.org/10.1111/j.1600-0714.2011.01044.x DOI

Bauvois B, Susin SA (2018) Revisiting Neutrophil Gelatinase-Associated Lipocalin (NGAL) in cancer: saint or sinner? Cancer 10(9):336. https://doi.org/10.3390/cancers10090336 DOI

Bissell MJ, Barcellos-Hoff MH (1987) The influence of extracellular matrix on gene expression: is structure the message? J Cell Sci Suppl 8:327–343. https://doi.org/10.1242/jcs.1987.supplement_8.18 DOI

Burger AM, Leyland-Jones B, Banerjee K, Spyropoulos DD, Seth AK (2005) Essential roles of IGFBP-3 and IGFBP-rP1 in breast cancer. Eur J Cancer 41:1515–1527

Canfield A, Schor AM, Schor SL, Grant ME (1986) The biosynthesis of extracellular matrix components by bovine retinal endothelial cells displaying distinctive morphological phenotypes. Biochem J 235:375–383

Canfield AE, Boot-Handford RP, Schor AM (1990) Thrombospondin gene expression by endothelial cells in culture is modulated by cell proliferation, cell shape and the substratum. Biochem J 268:225–230

Carito V, Bonuccelli G, Martinez-Outschoorn UE, Whitaker-Menezes D, Caroleo MC, Cione E, Howell A, Pestell RG, Lisanti MP, Sotgia F (2012) Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth. Cell Cycle 11(18):3403–3414. https://doi.org/10.4161/cc.21701 DOI

Chandrachud LM, Pendleton N, Chisholm DM, Horan MA, Schor AM (1997) Relationship between vascularity, age and survival in non-small cell lung cancer. Br J Cancer 76:1367–1375

Chen J, Grant ME, Schor AM, Schor SL (1989) Differences between adult and foetal fibroblasts in the regulation of hyaluronate synthesis: correlation with migratory activity. J Cell Sci 94:577–589

Deng X, Ma Q, Zhang B, Jiang H, Zhang Z, Wang Y (2013) Exp Cell Res 319(17):2545–2553. https://doi.org/10.1016/j.yexcr.2013.05.016 DOI

Durning P, Schor SL, Sellwood RAS (1984) Fibroblasts from patients with breast cancer show abnormal migratory behaviour in vitro. Lancet II:890–892

Ellis I, Grey AM, Schor AM, Schor SL (1992) Antagonistic effects of transforming growth factor beta and MSF on fibroblast migration and hyaluronic acid synthesis: possible implications for wound healing. J Cell Sci 102:447–456

Ellis I, Banyard J, Schor SL (1999) Motogenic and biosynthetic response of adult skin fibroblasts to TGFβ isoforms determined by “tissue response unit”. Cell Biol Int 23:593–602

Ellis IR, Schor AM, Schor SL (2007) EFG and TGF-α motogenic activities are mediated by the EGF receptor via distinct matrix-dependent mechanisms. Exp Cell Res 313:732–741

Ellis IR, Jones SJ, Lindsay Y, Ohe G, Schor AM, Schor SL, Leslie NR (2010a) Migration stimulating factor (MSF) promotes fibroblast migration by inhibiting AKT. Cell Signal 22:1655–1659

Ellis IR, Jones SJ, Staunton D, Vakonakis I, Norman DG, Potts JR, Milner CM, Meenan NA, Raibaud S, Ohea G, Schor AM, Schor SL (2010b) Multi-factorial modulation of IGD motogenic potential in MSF (migration stimulating factor). Exp Cell Res 316:2465–2476

Feng M, Feng J, Chen W, Wang W, Wu X, Zhang J, Xu F, Lai M (2016) Lipocalin2 suppresses metastasis of colorectal cancer by attenuating NF-κB-dependent activation of snail and epithelial mesenchymal transition. Mol Cancer 15(1):77. https://doi.org/10.1186/s12943-016-0564-9 DOI

Fernández CA, Yan L, Louis G, Yang J, Kutok JL, Moses MA (2005) The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11(15):5390–5395. https://doi.org/10.1158/1078-0432.CCR-04-2391 DOI

Gascard P, Tlsty TD (2016) Carcinoma-associated fibroblasts: orchestrating the composition of malignancy. Genes Dev 30(9):1002–1019. https://doi.org/10.1101/gad.279737.116 DOI

Gibson G, Schor SL, Grant ME (1982) Effects of matrix macromolecules on chondrocyte gene expression: synthesis of a low molecular weight collagen species by cells cultured within collagen gels. J Cell Biol 93:767–774

Grey AM, Schor AM, Rushton G, Ellis I, Schor SL (1989) Purification of the migration stimulating factor produced by fetal and cancer patient fibroblasts. Proc Natl Acad Sci U S A 86:2438–2442

Guo Y, Zhai J, Zhang J, Zhou H (2020) NGAL protects in nasopharyngeal carcinoma by inducing apoptosis and blocking Epithelial-Mesenchymal transition. Oncol Lett 19(6):3711–3718. https://doi.org/10.3892/ol.2020.11527 DOI

Haggie J, Schor SL, Howell A, Birch JM, Sellwood RAS (1987) Fibroblasts from relatives of hereditary breast cancer patients display fetal-like behaviour in vitro. Lancet I:1455–1457

Houard X, Germain S, Gervais M, Michaud A, van den Brule F, Foidart JM, Noel A, Monnot C, Corvol P (2005) Migration-stimulating factor displays HEXXH-dependent catalytic activity important for promoting tumor cell migration. Int J Cancer 116:378–384

Hu H, Ran Y, Zhang Y, Zhou Z, Harris SJ, Yu L, Sun L, Pan J, Liu J, Lou J, Yang Z (2009) Antibody library-based tumor endothelial cells surface proteomic functional screen reveals migration-stimulating factor as an anti-angiogenic target. Mol Cell Proteomics 8(4):816–826. https://doi.org/10.1074/mcp.M800331-MCP200 DOI

Hynes R (1990) Fibronectins. Springer, New York

Irwin CR, Picardo M, Ellis I, Sloan P, Grey AM, McGurk M, Schor SL (1994) Inter- and intrasite heterogeneity in the expression of fetal-like phenotypic characteristics by gingival fibroblasts: potential significance for wound healing. J Cell Sci 107:1333–1346

Jin L, Shen F, Weinfeld M, Sergi C (2020) Insulin growth factor binding protein 7 (IGFBP7)-related cancer and IGFBP3 and IGFBP7 crosstalk. Front Oncol 10:727. https://doi.org/10.3389/fonc.2020.00727 DOI

Jones SJ, Florence MM, Ellis IR, Kankova K, Schor SL, Schor AM (2007) Co-expression by keratinocytes of migration stimulating factor (MSF) and a functional inhibitor of its bioactivity. Exp Cell Res 313:4145–4157

Kay RA, Ellis IR, Jones SJ, Perrier S, Florence MM, Schor AM, Schor SL (2005) The expression of MSF, a potent onco-fetal cytokine, is uniquely controlled by 3’ UTR-dependent nuclear sequestration of its precursor mRNA. Cancer Res 65:10742–10749

Keatch RP, Armoogum K, Schor SL, Pridham MS, Banks K, Khor TY, Matthew C (2002) Microengineering as a tool to study substratum modulation of cell behaviour. Biomed Tech (Berl) 47S:386–389

Keatch RP, Schor AM, Vorstius JB, Schor SL (2012) Biomaterials in regenerative medicine: engineering to recapitulate the natural. Curr Opin Biotechnol 23:579–582. https://doi.org/10.1016/j.copbio.2012.01.017 DOI

Li Y, Xi Y, Zhu G, Jia J, Huang H, Liu Y, Guo Y, Liu (2019) Downregulated IGFBP7 facilitates liver metastasis by modulating epithelial-mesenchymal transition in colon cancer. Oncol Rep 42(5):1935–1945. https://doi.org/10.3892/or.2019.7303 DOI

Liu X, Zhao Q, Collodi P (2003) A truncated form of fibronectin is expressed in fish and mammals. Matrix Biol 22(5):393–396. doi: https://doi.org/10.1016/s0945-053x(03)00071-4.PMID : 14614986

Millard CJ, Ellis IR, Pickford AR, Schor AM, Schor SL, Campbell ID (2007) The role of fibronectin IGD motif in stimulating fibroblast migration. J Biol Chem 282:35530–35535

Mishra R, Haldar S, Suchanti S, Bhowmick NA (2019) Epigenetic changes in fibroblasts drive cancer metabolism and differentiation. Endocr Relat Cancer 26(12):R673–R688. https://doi.org/10.1530/ERC-19-0347 DOI

Moinfar F, Man YG, Arnould L, Bratthauer GL, Ratschek M, Tavassoli FA (2000) Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis. Cancer Res 60:2562–2566

Motegi K, Harada K, Pazouki S, Baillie R, Schor AM (2002) Evidence of a bi-phasic effect of thrombospondin-1 on angiogenesis. Histochem J 34:411–421

Motegi K, Harada K, Ohe G, Jones SJ, Ellis IR, Crouch DH, Schor SL, Schor AM (2008) Differential involvement of TGF-β1 in mediating the motogenic effects of TSP-1 on endothelial cells, fibroblasts and oral tumour cells. Exp Cell Res 314:2323–2333

Olumi AF, Grossfeld GD, Hayward SW, Carroll PR, Tlsty TD, Cunha GR (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59(19):5002–5011. https://doi.org/10.1186/bcr138 DOI

Pazouki S, Chisholm DM, Adi MM, Carmichael G, Farquharson M, Ogden GR, Schor SL, Schor AM (1997) The association between tumour progression and vascularity in the oral mucosa. J Pathol 183:39–43

Pendleton N, Pazouki S, Heerkens E, Smither RL, Chisholm DM, Moore JV, Howell A, Horan MA, Schor AM (1998) Relationships between different measurements of vascularity and clinico-pathological parameters in breast cancer. Anticancer Res 18:4565–4568

Perrier S, Woolston A, Purdie CA, Kazmi S, Preece PE, Davey KJ, Schor SL, Schor AM (2012) Migration stimulating factor (MSF): a novel biomarker of breast cancer progression. Trans Medic S1:003. https://doi.org/10.4172/2161-1025.S1-003 DOI

Picardo M, Schor SL, Grey AM, Howell A, Laidlaw I, Redford J, Schor AM (1991) The presence of migration stimulating activity in the serum of breast cancer patients. Lancet 337:130–133

Picardo M, McGurk M, Schor SL (1992) Identification of migration stimulating factor in wound fluid. Exp Mol Pathol 57:8–21

Prazeres P, Leonel C, Silva WN, Rocha B, Santos G, Costa AC, Picoli CC, Sena I, Gonçalves WA, Vieira MS, Costa P, Campos L, Lopes M, Costa MR, Resende RR, Cunha TM, Mintz A, Birbrair A (2020) Ablation of sensory nerves favours melanoma progression. J Cell Mol Med. https://doi.org/10.1111/jcmm.15381

Sahai E, Astsaturov I, Cukierman E et al (2020) A framework for advancing our understanding of cancer-associated fibroblasts. Nat Rev Cancer 20(3):174–186. https://doi.org/10.1038/s41568-019-0238-1 DOI

Sato Y, Inokuchi M, Takagi Y, Otsuki S, Fujimori Y, Yanaka Y, Kobayashi K, Higuchi K, Kojima K, Kawano T (2015) Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer. J Clin Pathol 68(10):795–801. https://doi.org/10.1136/jclinpath-2015-202987 DOI

Schor SL (1980a) Cell proliferation and migration within three-dimensional collagen gels. J Cell Sci 41:159–175

Schor SL (1980b) The effects of EGTA and trypsin on cell attachment to collagen. J Cell Sci 40:271–279

Schor SL (1994) Cytokine control of cell motility: modulation and mediation by the extracellular matrix. Prog Growth Factor Res 5:223–248

Schor SL (1995) Fibroblast subpopulations as accelerators of tumor progression: role of migration stimulating factor. In: Goldberg I, Rosen E (eds) Epithelial mesenchymal interactions in cancer. Birkhauser Press, Basel, pp 273–296

Schor AM, Canfield AE (1993) Role of the extracellular matrix in angiogenesis: xylosides inhibit matrix biosynthesis and sprouting in endothelial cells in culture. Eur Respir Rev 3:644–649

Schor SL, Court J (1979) Different mechanisms involved in the attachment of cells to native and denatured collagen. J Cell Sci 38:267–281

Schor AM, Schor SL (1986) The isolation and culture of endothelial cells and pericytes from bovine retinal microvasculature: a comparative study with large vessel vascular cells. Microvasc Res 32:21–38

Schor SL, Schor AM (1987a) Fetal-to-adult transitions in fibroblast phenotype: their possible relevance to the pathogenesis of cancer. J Cell Sci Suppl 8:165–180

Schor SL, Schor AM (1987b) Clonal heterogeneity in fibroblast phenotype: implications for the control of epithelial-mesenchymal interactions. Bio Essays 7:200–204

Schor AM, Schor SL (1988) Inhibition of endothelial cell morphogenetic interactions in vitro by alpha- and beta-xylosides. In Vitro 24:659–668

Schor SL, Schor AM (1997) Stromal acceleration of tumour progression: role of “fetal-like” fibroblast subpopulations. Pathol Update 4:75–95

Schor SL, Schor AM (2001) Tumour-stroma interactions. Phenotypic and genetic alterations in mammary stroma: implications for tumour progression. Breast Cancer Res 3:373–379

Schor AM, Schor SL (2010) Angiogenesis and tumour progression: migration-stimulating factor as a novel target for clinical intervention. Eye 24:450–458

Schor AM, Schor SL (2011) Multiple fibroblast phenotypes in cancer patients. In: Mueller M, Fusenig N (eds) Tumor-associated fibroblasts and their matrix, The tumor microenvironment 4. Springer, Heidelberg, pp 197–223

Schor AM, Schor SL, Weiss JB, Brown RA, Kumar S, Phillips P (1980) A requirement for native collagen in the mitogenic effect of a low molecular weight angiogenic factor on endothelial cells in culture. Brit J Cancer 41:790–799

Schor SL, Schor AM, Bazill G (1981a) The effects of fibronectin on the migration of human skin fibroblasts and Syrian hamster melanoma cells on collagen. J Cell Sci 48:301–314

Schor SL, Schor AM, Bazill G (1981b) The effects of fibronectin on the migration and adhesion of Chinese hamster ovary cells on collagen. J Cell Sci 49:299–310

Schor SL, Allen TD, Harrison CJ (1981c) Cell migration into 3D gels of native collagen fibres: collagenolytic activity not required for the migration of two permanent cell lines. J Cell Sci 46:171–186

Schor SL, Schor AM, Winn B, Rushton G (1982) The use of 3D collagen gels for the study of tumour cell invasion in vitro: experimental parameters influencing cell migration into the gel matrix. Int J Cancer 29:57–62

Schor AM, Schor SL, Allen TD (1983) The effects of culture conditions on the proliferation and morphology of bovine aortic endothelial cells in vitro: reversible expression of the sprouting cell phenotype. J Cell Sci 62:267–285

Schor SL, Schor AM, Allen TD, Winn B (1985a) The interaction of melanoma cells with fibroblasts and endothelial cells in three-dimensional macromolecular matrices: a model of tumour cell invasion. Int J Cancer 36:93–102

Schor SL, Schor AM, Durning P, Rushton G (1985b) Skin fibroblasts obtained from cancer patients display a fetal-like migratory behaviour on collagen gels. J Cell Sci 73:235–244

Schor SL, Schor AM, Rushton G, Smith L (1985c) Adult, fetal and transformed fibroblasts display different migratory phenotypes on collagen gels: evidence for an isoformic transition during fetal development. J Cell Sci 73:221–234

Schor SL, Haggie J, Durning P, Howell A, Sellwood RAS, Crowther D (1986) The occurrence of a foetal fibroblast phenotype in familial breast cancer. Int J Cancer 37:831–836

Schor SL, Schor AM, Howell A, Crowther D (1987) Hypothesis: persistent expression of fetal phenotypic characteristics by fibroblasts is associated with an increased susceptibility to neoplastic disease. Exp Cell Biol 55:11–17

Schor SL, Schor AM, Grey AM, Rushton G (1988a) Fetal and cancer patient fibroblasts produce an autocrine migration-stimulating factor not made by normal adult cells. J Cell Sci 90:391–399

Schor SL, Schor AM, Rushton G (1988b) Fibroblasts from cancer patients display a mixture of both fetal and adult-like phenotypic characteristics. J Cell Sci 90:401–407

Schor SL, Schor AM, Grey AM, Chen J, Rushton G, Grant ME, Ellis I (1989) Mechanism of action of the migration stimulating factor (MSF) produced by fetal and cancer patient fibroblasts: effect on hyaluronic acid synthesis. In Vitro 25:737–746

Schor SL, Grey AM, Picardo M, Schor AM, Howell A, Ellis I, Rushton G (1991) Heterogeneity amongst fibroblasts in the production of migration stimulating factor (MSF): implications for cancer pathogenesis. In: Goldberg I (ed) Cell Motility Factors. Birkhauser Press, Basel, pp 127–146

Schor AM, Rushton G, Ferguson JE, Howell A, Redford J, Schor SL (1994) Phenotypic heterogeneity in breast fibroblasts – functional anomaly in fibroblasts from histologically normal tissue adjacent to carcinoma. Int J Cancer 59:25–32.

Schor SL, Ellis I, Dolman C, Banyard J, Humphries MJ, Mosher DF, Grey AM, Mould AP, Sotille J, Schor AM (1996) Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J Cell Sci 109:2581–2590

Schor AM, Pazouki S, Morris J, Smither RL, Chandrachud LM, Pendleton N (1998c) Heterogeneity in microvascular density in lung tumours. Comparison with normal bronchus. Br J Cancer 77:946–951

Schor AM, Pendleton N, Pazouki S, Smither RL, Morris J, Lessan K, Heerkens E, Chandrachud LM, Carmichael G, Adi M, Chisholm DM, Stevenson H (1998d) Assessment of vascularity in histological sections: Effects of methodology and value as an index of angiogenesis in breast tumours. Histochem J 30:849–856

Schor SL, Ellis I, Banyard J, Schor AM (1999) Motogenic activity of IGD-containing synthetic peptides. J Cell Sci 112:3879–3888

Schor AM, Ellis I, Schor SL (2001) Collagen gel assay for angiogenesis. Induction of endothelial cell sprouting. In: Murray JC (ed) Methods in molecular medicine, Vol 46: Angiogenesis protocols. Humana Press, Totowa, pp 145–162

Schor SL, Ellis IR, Jones SJ, Baillie R, Seneviratne K, Clausen J, Motegi K, Vojtesek B, Kankova K, Furrie E, Sales MJ, Schor AM, Kay R (2003) Migration-stimulating factor: a genetically truncated onco-fetal fibronectin isoform expressed by carcinoma and tumor-associated stromal cells. Cancer Res 63:8827–8836

Schor SL, Schor AM, Keatch RP, Belch JJF (2005) Role of matrix macromolecules in the aetiology and treatment of chronic ulcers. In: Lee BY (ed) The wound management manual. McGraw Hill, New York, pp 109–121

Schor SL, Ellis IR, Harada K, Motegi K, Anderson AR, Chaplain MR, Keatch RP, Schor AM (2006) A novel ‘sandwich’ assay for quantifying chemo-regulated cell migration within 3-dimensional matrices: wound healing cytokines exhibit distinct motogenic activities compared to the transmembrane assay. Cell Motil Cytoskeleton 63:287–300

Schor SL, Schor AM, Ellis IR, Jones SJ, Florence MM, Cox J, Woolston AM (2009) The oncofetal paradigm revisited: MSF and HA as contextual drivers of cancer progression. In: Stern R (ed) Hyaluronan in cancer biology. Academic Press, pp 285–306

Schor SL, Ellis IR, Jones SJ, Woolston AM, Schor AM (2012) Bi-stable switch in MSF expression is regulated by the concerted signalling of TGFβ1 and the extracellular matrix. Int J Cancer 130:2024–2032. https://doi.org/10.1002/ijc.26213 DOI

Schor AM, Kankova K, Woolstson AM, Vojtesek B, Felts PA (2020). Characterisation of antibodies to Migration Stimulating Factor (MSF). Detection of MSF isoforms. https://doi.org/10.20933/100001167

Solinas G, Schiarea S, Liguori M, Fabbri M, Pesce S, Zammataro L, Pasqualini F, Nebuloni M, Chiabrando C, Mantovani A, Allavena P (2010) Tumor-conditioned macrophages secrete migration-stimulating factor: a new marker for M2-polarization, influencing tumor cell motility. J Immunol 185:642–652. https://doi.org/10.4049/jimmunol.1000413 . Epub 2010 Jun 7 DOI

Vakonakis I, Staunton D, Ellis IR, Sarkies P, Flanagan A, Schor AM, Schor SL, Campbell ID (2009) Motogenic sites in human fibronectin are masked by long range interactions. J Biol Chem 284:15668–15675

Yoshino I, Kometani T, Shoji F, Osoegawa A, Ohba T, Kouso H, Takenaka T, Yohena T, Maehara Y (2007) Induction of epithelial-mesenchymal transition-related genes by benzo[a]pyrene in lung cancer cells. Cancer 110:369–374

Zhao Q, Liu X, Collodi P (2001) Identification and characterization of a novel Fibronectin in Zebrafish. Exp Cell Res 268:211–219. https://doi.org/10.1006/excr.2001.5291 DOI